Related Experiment Video
Updated: Jun 17, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Use of Financial Incentives to Promote Adolescent Type 1 Diabetes Self-management: A Pilot Randomized Controlled
Faisal S Malik1,2, Tom Chen3, Maria Manzueta2
1Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.
Financial incentives improved diabetes self-management behaviors and time in range (TIR) in adolescents with type 1 diabetes (T1D). These gains were observed in the short-term, with no significant impact on A1C levels.
Area of Science:
- Pediatric Endocrinology
- Behavioral Economics
- Diabetes Management
Background:
- Adolescents with type 1 diabetes (T1D) face challenges in self-management.
- Improving adherence to self-care behaviors is crucial for glycemic control.
- Financial incentives are being explored as a motivational tool.
Purpose of the Study:
- To assess the impact of financial incentives on self-management behaviors.
- To evaluate the effect of financial incentives on glycemic control (measured by Time in Range - TIR and A1C).
- To compare different incentive frames (gain vs. loss) against a no-incentive control.
Main Methods:
- A crossover randomized controlled trial involving adolescents aged 12-18 with T1D.
- Participants set personalized self-management and clinical outcome goals.
- Three treatment arms were used: gain frame incentives, loss frame incentives, and no incentives, each lasting 12 weeks.
Main Results:
- Behavioral goal attainment was significantly higher with financial incentives (50% gain frame, 45% loss frame) compared to no incentives (41%).
- Mean Time in Range (TIR) improved significantly with financial incentives (43% gain frame, 42% loss frame) versus no incentives (38%).
- No significant differences in A1C levels were observed across the three treatment arms.
Conclusions:
- Financial incentives can effectively enhance diabetes self-management behaviors in adolescents with T1D.
- Incentives led to short-term improvements in TIR, a key indicator of glycemic control.
- Further research may be needed to explore long-term effects and A1C impact.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones

